Role of high-throughput sequencing in oncology;Place des technologies de séquençage haut débit en oncologie

Bulletin du Cancer

Volumn 100, Issue 3, 2013, Pages 295-301

  Rodrigues, Manuel Jorge ^a,b   Gomez Roca, Carlos ^c  

^a INSTITUT CURIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Cancer; High throughput technology; Tailored medicine; Targeted therapy

Indexed keywords

ARTICLE; HIGH THROUGHPUT SEQUENCING; NEOPLASM; ONCOLOGY;

EID: 84876562045     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2013.1717     Document Type: Article

References (29)

1. Gilabert M, Audebert S, Viens P, Borg JP, Bertucci F, Goncalves A. Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers. Bull Cancer 2010; 97 : 321-39.
2. Bieche I. Search for new genes involved in breast tumorigenesis by "Omics" analysis. Bull Cancer 2010; 97 : 1365-80.
3. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409 : 860-921. (Pubitemid 32165345)
4. Rothberg JM, Hinz W, Rearick TM, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011; 475 : 348-52.
5. Loman NJ, Misra RV, Dallman TJ, et al. Performance comparison of benchtop high-Throughput sequencing platforms. Nat Biotechnol 2012; 30 : 434-9.
6. Schadt EE, Linderman MD, Sorenson J, Lee L, Nolan GP. Computational solutions to large-scale data management and analysis. Nat Rev Genet 2010; 11 : 647-57.
7. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009; 360 : 2719-29.
8. Ramsingh G, Koboldt DC, Trissal M, et al. Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Blood 2010; 116 : 5316-26.
9. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009; 27 : 182-9.
10. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 2009; 106 : 19096-101.
11. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472 : 90-4.
12. Peters BA, Kermani BG, Sparks AB, et al. Accuratewhole-genome sequencing and haplotyping from 10 to 20 human cells. Nature 2012; 487 : 190-5.
13. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366 : 883-92.
14. Binladen J, Gilbert MT, Bollback JP, et al. The use of coded PCR primers enables high-Throughput sequencing of multiple homolog amplification products by 454 parallel sequencing. PLoS One 2007; 2 : e197.
15. Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O. The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One 2009; 4 : e4932.
16. Bormann Chung CA, Boyd VL, McKernan KJ, et al. Whole methylome analysis by ultra-deep sequencing using two-base encoding. PLoS One 2010; 5 : e9320.
17. Bredel M, Scholtens DM, Yadav AK, et al. NFKBIA deletion in glioblastomas. N Engl J Med 2011; 364 : 627-37.
18. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361 : 1058-66.
19. Takeuchi K, Soda M, Togashi Y, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012; 18 : 378-81.
20. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairycell leukemia. N Engl J Med 2011; 364 : 2305-15.
21. Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363 : 2424-33.
22. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360 : 765-73.
23. Bertolotto C, Lesueur F, Giuliano S, et al. A SUMOylationdefective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011; 480 : 94-8.
24. Bonaiti-Pellie C, Andrieu N, Arveux P, et al. Cancer genetics: estimation of the needs of the population in France for the next ten years. Bull Cancer 2009; 96 : 875-900.
25. Orbach D. Birth notice: a new bone sarcoma has been born. Bull Cancer 2012; 99 : 512.
26. Pierron G, Tirode F, Lucchesi C, et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 2012; 44 : 461-6.
27. von Hoff DD, Stephenson Jr. JJ, Rosen P, et al. Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol 2010; 28 : 4877-83.
28. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14 : 985-90.
29. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463 : 184-90.